Clinical trial / 2005
Comprehensive lifestyle changes for 1 year decreased PSA and inhibited prostate cancer cell growth in men with early, low-grade prostate cancer.
Ninety-three men with early, biopsy-proven prostate cancer who chose no conventional treatment were randomized to comprehensive lifestyle changes or a usual care control group for 1 year. None of the experimental group patients but 6 control patients underwent conventional treatment due to an increase in PSA or disease progression on MRI. PSA decreased 4% in the experimental group while increasing 6% in controls (p = 0.016). Serum from the experimental group inhibited LNCaP cell growth nearly 8 times more than control serum (70% vs. 9%, p < 0.001), and changes were significantly associated with the degree of lifestyle change.
- Study type
- Randomized controlled trial
- Who was studied
- 93 men with early, biopsy-proven prostate cancer (PSA 4-10 ng/ml, Gleason scores <7) who chose not to undergo conventional treatment
- What was measured
- Prostate specific antigen (PSA), treatment trends, and serum-stimulated LNCaP cell growth after 1 year
THE PAPER
Intensive lifestyle changes may affect the progression of prostate cancer.
Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, Barnard RJ, Aronson WJ, McCormac P, McKnight DJ, Fein JD, Dnistrian AM, Weinstein J, Ngo TH, Mendell NR, Carroll PR. J Urol, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.